Beneficial effects of coenzyme Q10 in streptozotocin-induced type I diabetic rats

Iranian Journal of Pharmacology and Therapeutics

Volumn 5, Issue 1, 2006, Pages 61-65

  Modi, Ketan P ^a,b   Vishwakarma, Santosh L ^a,b   Goyal, Ramesh K ^a,b   Bhatt, Parloop A ^b  

^a Shri B M Shah College of Pharmacy Modasa   (India)

^b L M COLLEGE OF PHARMACY   (India)

Author keywords

Coenzyme Q10; Diabetes; Streptozotocin

Indexed keywords

CHOLESTEROL; DIMETHYL SULFOXIDE; GLUCOSE; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN; PENTOBARBITAL; STREPTOZOCIN; TRIACYLGLYCEROL; UBIDECARENONE; VERY LOW DENSITY LIPOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; BLOOD PRESSURE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG EFFECT; GLUCOSE BLOOD LEVEL; HEART RATE; HYPERCHOLESTEROLEMIA; HYPERTRIGLYCERIDEMIA; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; LIPID PEROXIDATION; MALE; NONHUMAN; RAT; STREPTOZOCIN DIABETES; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 40149105386     PISSN: 17352657     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Malaisse WJ, Malaisse-Lagae F, Sener A, et al. Determinants of selective toxicity of alloxan to the pancreatic β cell. Proc Natl Acad Sci 1982; 79:927-30.
2. Wolff SP, Dean RT. Glucos autoxidation and protein modification. The potential role 'autoxidative glycosylation' in diabetes. Biochem J 1987; 245:243-50.
3. Hunt JV, Dean RT, Wolff SP. Hydroxyl radical production and autooxidative glycosylation: glucose autoxidation as the cause of protein damage in the experimental glycation model of diabetes mellitus and ageing. Biochem J 1988; 256:205-12.
4. Baynes JW. Role of oxidative stress in development of complications of diabetes. Diabetes 1991; 40:405-12.
5. Wolff SP. Diabetes mellitus and free radicals. Br Med Bull 1993; 49:642-52.
6. Maxwell SRJ, Thomason H, Sandler D, et al. Antioxidant status in patients with uncomplicated insulin-dependent and non-insulin diabetes mellitus. Eur J Clin Invest 1997; 46:484-90.
7. Ernster L, Dallner G. Biochemical, physiological and medical aspects of ubiquinone function. Biochim Biophys Acta 1995; 1271:195-204.
8. Ernster L, Forsmark P, Nordenbrand K. The mode of action of lipid-soluble antioxidants in biological membranes: relationship between the effects of ubiquinol and vitamin E as inhibitors of lipid peroxidation in submitochondrial particles. Biofactors 1992; 3:241-8.
9. Yuting C, Rongliang Z, Zhongjiani J, et al. Flavanoids as superoxide scavengers and as antioxidants. Free Rad Biol Med 1990; 9:19-21.
10. Lenaz G, Bovina C, Formiggini G, et al. Mitochondria, oxidative stress and antioxidant defense. Acta Biochim Pol 1999; 46:1-21.
11. Bargossi AM, Battno M, Gaddi A, et al. Exogenous CoQ10 preserves plasma uboquinone levels in patients treated with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors. Int J Clin Lab Res 1994; 24:171-6.
12. Shoffner JM, Wallace DC. Oxidative phosphorylation diseases and mitochondrial DNA mutations: diagnosis and treatment. Annu Rev Nutr 1994; 14:535-68.
13. Fadic R, Johns DR. Treatment of the mitochondrial encephalomyopathies. In: Beal MF, Howell N, Bodis-Wollner I, eds. Mitochondria and free radicals in neurodegerative disease. New York, USA: wiley-liss; 1997:537-55.
14. rd. Effects of coenzyme Q10 treatment on antioxidant pathways in normal and streptozotocin-induced diabetic rats. J Biochem Mol Toxicol 2001; 15:41-6.
15. Singh RB, Niaz MA, Rastogi SS, et al. Effect of hydrosoluble coenzyme Q10 on blood pressures and insulin resistance in hypertensive patients with coronary artery disease. J Hum Hypertens 1999; 13:203-8.
16. Ohkawa H, Ohishi N, yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979; 95:351.
17. Umarani DN, Goyal RK. Beneficial effects of fenoldopam treatment on renal function in streptozotocin-induced diabetic rats. Clin Exp Hypertens 2002; 24:207-19.
18. Akhani SP, Vishwakarma SL, Goyal RK. Anti-diabetic activity of Zingiber officinale in streptozotocin-induced type I diabetic rats. J Pharm Pharmacol 2004; 56:101-5.
19. Niaz MA, Singh RB, Rastogi SS. Effect of hydroslouble coenzyme Q10 on the lipoprotein (a) and insulin sensitivity in rabbits receiving trans-fatty acid rich diet. J trace Elem Exp Med 1998; 11:275-88.
20. Singh RB, Shinde SN, Chopra RK, et al. Effect of coenzyme Q10 on experimental atherosclerosis and chemical composition and quality of atheroma in rabbits. Atherosclerosis 2000; 148:275-82.
21. Serizawa T, Oku J, Iizuka M, et al. Beneficial effects of coenzyme Q10 on impaired left ventricular performance in streptozotocin diabetic rats. Jpn Heart J 1988; 29:233-42.
22. Singh RB, Niaz MA. Serum concentration of lipoprotein (a) decreases on treatment with hydrosoluble coenzyme Q10 in patients with coronary artery disease: discovery of a new role. Int J Cardiol 1999; 68:23-9.